Ep. 302: The 411 on H5N1, and Looking Back on the Dawn of Molecular Diagnostics

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/ce/75/ae/ce75aee0-f2bb-e1ce-07b3-0a803fdd11d0/mza_6020898618459591687.jpg/600x600bb.jpg

Halteres Presents

Halteres Associates

30 episodes

1 week ago

Halteres Presents is an award-winning, brand-agnostic interview podcast designed to unbiasedly highlight the happenings within the diagnostics industry. In each episode, founding partner Mickey Urdea and managing partner Rich Thayer interview an expert who brings their own unique perspective to an industry topic. https://youtu.be/OmbeM2uGkHo Halteres Associates is a leading bioscience consultancy with extensive, long-term, direct operating experience in a broad spectrum of areas of expertise, including diagnostics, medical devices, therapeutics, research reagents, and bioscience tools.

Life Sciences

Science

RSS

All content for Halteres Presents is the property of Halteres Associates and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/31890490/31890490-1717185265955-fe4e6b60b7f83.jpg

Ep. 302: The 411 on H5N1, and Looking Back on the Dawn of Molecular Diagnostics - David Persing

Halteres Presents

40 minutes 52 seconds

1 year ago

Ep. 302: The 411 on H5N1, and Looking Back on the Dawn of Molecular Diagnostics - David Persing

On this episode of "Halteres Presents", Rich and Mickey are sitting down with David Persing, the Executive Vice President, Chief Medical and Scientific Officer for Cepheid, to reflect upon his experiences at the dawn of molecular diagnostics, the effectiveness of surveilling animal reservoirs to monitor for disease outbreaks, and just how nervous we should be about the spread of H5N1 (and when we should really start to worry).

David Persing, MD, Ph.D., has spent most of his 30-year career in biomarker discovery, translational medicine, and innovation in the diagnostics space. Dave joined Cepheid in 2005 and has focused on the enablement of molecular diagnostic technology to meet global needs in infectious diseases and oncology. He conducted his scientific and medical training with Don Ganem and Nobel laureate Harold Varmus at the University of California, San Francisco. After residency training in Clinical Pathology at Yale University, he held leadership roles in academia and industry starting in the early 1990s with the design, implementation, and operation of the first PCR reference laboratory at the Mayo Clinic.

His interest in the democratization of molecular diagnostic methods has been longstanding, starting in 1993 with his publication of the first of five widely adopted textbooks to include PCR protocols and guidelines for laboratory operations. He has published over 300 peer-reviewed articles and reviews, including multiple articles in the New England Journal of Medicine, Science, and PNAS. In 2020, he was named to the Fierce Pharma list of the 22 most influential scientists in the fight against COVID-19. To maintain a connection with the latest trends in translational medicine, Dave also serves as Consulting Professor of Pathology at Stanford University School of Medicine. He obtained his MD and Ph.D. degrees from UCSF in 1988.

This episode of "Halteres Presents" is brought to you by the UC San Diego Extended Studies In Vitro Diagnostics Product Development course, a unique live-online program designed for managers, entrepreneurs, investors, and scientists. Enroll today and use our exclusive discount code HALTERES10 at checkout for 10% off the price of your enrollment.

⁠⁠UC San Diego Extended Studies In Vitro Diagnostics Product Development Course⁠⁠

Use code: HALTERES10 at checkout!

Learn more about Halteres Associates ⁠⁠⁠⁠⁠⁠⁠HERE⁠⁠⁠⁠⁠⁠⁠.